Wade K, Brady MF, Thai T, Want Y, Zheng B, Salani R, Tewari KS, Gray HJ, Bakkum-Gamez JN, Burger RA, Moore KN, Bookman MA: Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218 Gynecol Oncol 155 (1): 69 - 74,2019.
Oved JH, Graul A, Burger RA, Schwartz LE, Reyes MC, Balis FM.: Exceptional Response to Nivolumab in a 13 year old female with metastatic HPV Negative Cervical Carcinoma DNA and Cell Biology 38 (10): 1143 - 1146,2019.
Tewari KT, Burger RA, Enserro D, Norquist BM, Swisher EM, Brady MF, Bookman MA, Fleming GF, Huang H, Homesley HD, Fowler JM, Greer BE, Boente M, Liang SX, Ye C, Bais C, Randall LM, Chan JK, Ferriss JS, Coleman RL, Aghajanian C, Herzog TJ, DiSaia PJ, Copeland LJ, Mannel RS, Birrer MJ, Monk BJ.: Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer. J Clin Oncol 37 (26): 2317 - 2328,2019.
Fuh K, Java JJ, Chan JK, Kapp DS, Monk BJ, Burger RA, Young RC, Alberts DS, McGuire WP, Markman M, Bell J, Ozols RF, Armstrong DK, Aghajanian C, Bookman MA, Mannel RS: Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients Gynecol Oncol 154 (2): 420 - 425,2019.
Nasioudis D, Haggerty AF, Giuntoli II RL, Burger RA, Morgan MA, Ko EM, Latif NA.: Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma. Gynecol Oncol 154 (2): 302 - 307,2019.
Moore KN, Gunderson C, Sabbatini P, McMeekin DS, Mantia-Smaldone G, Burger R, Morgan MA, Kapoun AM, Brachmann RK, Stagg R, Farooki A, O'Cearbhaill RE: A Phase 1b Dose Escalation Study of Ipafricept (OMP-54F28) in Combination with Paclitaxel and Carboplatin in Patients with Recurrent Platinum-Sensitive Ovarian Cancer Gynecol Oncol 154 (2): 294 - 301,2019.
Fruehauf JP, Parmakhtiar B, Burger RA, Kim J-H: HIF inactivation of p53 in Ovarian Cancer Can be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity Molecular Cancer Research 17 (8): 1675 - 1686,2019.
Cori L, Cha B, Ellenberg S, Bogner HR, Hwang W-T, Smith J, Haggerty A, Morgan M, Burger R, Chu C, Ko E: Effects of Educational Interventions on Human Papillomavirus Vaccine Acceptability: A Randomized Controlled Trial
Obstetrics and Gynecology 134 (2): 376 - 384,2019.
Graul A, Haggerty A, Stickley C, Kumar P, Morales K, Bogner H, Burger R, Morgan M, Ko E.: Effect of patient education on palliative care knowledge and acceptability of outpatient palliative care service among gynecologic oncology patients. Poster Presentation, Annual Meeting of the American Society of Clinical Oncology. (Abstract) : 2019.
Cadoo KA, Meyers ML, Burger RA, Armstrong DK, Penson RT, Gordon MS, Fleming GF, Moroney JW, Hamilton EP, Duska LR, Wenham RM, Sankoh S, Brouwer S, Ordentlich P, Aghajanian C, Matulonis UA.: A phase II randomized study of avelumab plus entinostat versus avelumab plus placebo in patients (pts) with advanced epithelial ovarian cancer (EOC). Clinical Science Symposium Presentation at the Annual Meeting of the American Society of Clinical Oncology (Abstract) : 2019.